Oxaliplatin
Categoria
Oxaliplatin Nombres de marca, Oxaliplatin Analogos
Oxaliplatin Marca los nombres de mezcla
Oxaliplatin Formula quimica
Oxaliplatin RX enlace
Oxaliplatin FDA hoja
Oxaliplatin MSDS (hoja de seguridad de materiales)
Oxaliplatin Sintesis de referencia
Oxaliplatin Peso molecular
Oxaliplatin Punto de fusion
Oxaliplatin H2O Solubilidad
Oxaliplatin Estado
Oxaliplatin LogP
Oxaliplatin Formas de dosificacion
Oxaliplatin Indicacion
Oxaliplatin Farmacologia
Oxaliplatin Absorcion
Oxaliplatin Toxicidad
Oxaliplatin Informacion de Pacientes
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
